3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
2
Endometrial Neoplasms
2
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Prostatic Neoplasms
1
Pancreatic cancer, adult
1
Ovarian Germ Cell Cancer
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms
1
Lung Neoplasms
1
Hip Fractures
1
Glioblastoma
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
Carboplatin
8
Etoposide
7
Filgrastim
5
Bleomycin
5
Ifosfamide
4
Cisplatin
4
Thiotepa
3
Peripheral Blood Stem Cell Transplantation
3
Paclitaxel
3
Granulocyte Colony-Stimulating Factor
3
etoposide phosphate
2
Temozolomide
2
Taxes
2
Amifostine
2
sodium thiosulfate
1
ixabepilone
1
Vinblastine
1
Surgical Procedures, Operative
1
Reverse Transcriptase Polymerase Chain Reaction
1
Restraint, Physical
1
Radiotherapy
1
Psychiatric Rehabilitation
1
PT-100 dipeptide
1
Oxaliplatin
1
O(6)-benzylguanine
1
Microarray Analysis
1
Mesna
1
Melphalan
1
Immunohistochemistry
1
Hematologic Tests
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ovarian Germ Cell Cancer
×
Hematologic Tests
×
Gynecologic
×
Clear all
NCT06329323
2024-03-26
SUMMER
Imperial College London
Not yet recruiting
24 enrolled